These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 27536240)

  • 21. Involvement of α
    Alsufyani HA; Docherty JR
    Korean J Physiol Pharmacol; 2023 Jul; 27(4):325-331. PubMed ID: 37386830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The alpha-adrenoceptor antagonist, zolertine, inhibits alpha1D- and alpha1A-adrenoceptor-mediated vasoconstriction in vitro.
    Ibarra M; Hong E; Villalobos-Molina R
    J Auton Pharmacol; 2000 Jun; 20(3):139-45. PubMed ID: 11193002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of RS17053 on α
    Alsufyani HA; Docherty JR
    Fundam Clin Pharmacol; 2023 Dec; 37(6):1170-1178. PubMed ID: 37392126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alpha1A- and alpha1B-adrenoceptors are the major subtypes in human saphenous vein.
    Yan M; Sun J; Bird PI; Liu DL; Grigg M; Lim YL
    Life Sci; 2001 Jan; 68(10):1191-8. PubMed ID: 11228103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subtype-specific dimerization of alpha 1-adrenoceptors: effects on receptor expression and pharmacological properties.
    Uberti MA; Hall RA; Minneman KP
    Mol Pharmacol; 2003 Dec; 64(6):1379-90. PubMed ID: 14645668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Murine alpha1-adrenoceptor subtypes. I. Radioligand binding studies.
    Yang M; Reese J; Cotecchia S; Michel MC
    J Pharmacol Exp Ther; 1998 Aug; 286(2):841-7. PubMed ID: 9694940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction between α
    Alsufyani HA; Daly C; Docherty JR
    Basic Clin Pharmacol Toxicol; 2021 Dec; 129(6):416-426. PubMed ID: 34383990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The antipsychotic drug sertindole is a specific inhibitor of alpha1A-adrenoceptors in rat mesenteric small arteries.
    Ipsen M; Zhang Y; Dragsted N; Han C; Mulvany MJ
    Eur J Pharmacol; 1997 Oct; 336(1):29-35. PubMed ID: 9384251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pharmacology of α
    Docherty JR
    Eur J Pharmacol; 2019 Jul; 855():305-320. PubMed ID: 31067439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of alpha1-adrenoceptor subtypes mediating contractions to phenylephrine in rat thoracic aorta, mesenteric artery and pulmonary artery.
    Hussain MB; Marshall I
    Br J Pharmacol; 1997 Nov; 122(5):849-58. PubMed ID: 9384500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different roles of alpha1-adrenoceptor subtypes in mediating cardiomyocyte protein synthesis in neonatal rats.
    Zhang Y; Yan J; Chen K; Song Y; Lu Z; Chen M; Han C; Zhang Y
    Clin Exp Pharmacol Physiol; 2004 Sep; 31(9):626-33. PubMed ID: 15479171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Affinity of serotonin receptor antagonists and agonists to recombinant and native alpha1-adrenoceptor subtypes.
    Yoshio R; Taniguchi T; Itoh H; Muramatsu I
    Jpn J Pharmacol; 2001 Jun; 86(2):189-95. PubMed ID: 11459121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential antagonism by conotoxin rho-TIA of contractions mediated by distinct alpha1-adrenoceptor subtypes in rat vas deferens, spleen and aorta.
    Lima V; Mueller A; Kamikihara SY; Raymundi V; Alewood D; Lewis RJ; Chen Z; Minneman KP; Pupo AS
    Eur J Pharmacol; 2005 Jan; 508(1-3):183-92. PubMed ID: 15680270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological pleiotropism of the human recombinant alpha1A-adrenoceptor: implications for alpha1-adrenoceptor classification.
    Ford AP; Daniels DV; Chang DJ; Gever JR; Jasper JR; Lesnick JD; Clarke DE
    Br J Pharmacol; 1997 Jul; 121(6):1127-35. PubMed ID: 9249248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contraction of Rat Cauda Epididymis Smooth Muscle to
    Pacini ESA; Castilho ACS; Hebeler-Barbosa F; Pupo AS; Kiguti LRA
    J Pharmacol Exp Ther; 2018 Jul; 366(1):21-28. PubMed ID: 29685886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is alpha1D-adrenoceptor protein detectable in rat tissues?
    Yang M; Verfürth F; Büscher R; Michel MC
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Apr; 355(4):438-46. PubMed ID: 9109358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modification of alpha1 -adrenoceptors by peroxynitrite as a possible mechanism of systemic hypotension in sepsis.
    Takakura K; Taniguchi T; Muramatsu I; Takeuchi K; Fukuda S
    Crit Care Med; 2002 Apr; 30(4):894-9. PubMed ID: 11940765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro alpha1-adrenoceptor pharmacology of Ro 70-0004 and RS-100329, novel alpha1A-adrenoceptor selective antagonists.
    Williams TJ; Blue DR; Daniels DV; Davis B; Elworthy T; Gever JR; Kava MS; Morgans D; Padilla F; Tassa S; Vimont RL; Chapple CR; Chess-Williams R; Eglen RM; Clarke DE; Ford AP
    Br J Pharmacol; 1999 May; 127(1):252-8. PubMed ID: 10369480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of alpha1-adrenoceptor subtypes mediating vasoconstriction in rabbit cutaneous resistance arteries.
    Smith KM; Macmillan JB; McGrath JC
    Br J Pharmacol; 1997 Nov; 122(5):825-32. PubMed ID: 9384497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular activity of the chiral xanthone derivatives.
    Szkaradek N; Rapacz A; Pytka K; Filipek B; Żelaszczyk D; Szafrański P; Słoczyńska K; Marona H
    Bioorg Med Chem; 2015 Oct; 23(20):6714-24. PubMed ID: 26386822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.